Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

The role of donor-specific HLA alloantibodies in liver transplantation.

O'Leary JG, Demetris AJ, Friedman LS, Gebel HM, Halloran PF, Kirk AD, Knechtle SJ, McDiarmid SV, Shaked A, Terasaki PI, Tinckam KJ, Tomlanovich SJ, Wood KJ, Woodle ES, Zachary AA, Klintmalm GB.

Am J Transplant. 2014 Apr;14(4):779-87. doi: 10.1111/ajt.12667. Epub 2014 Mar 1.

PMID:
24580828
[PubMed - in process]
2.

Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death.

Fidler SJ, Irish AB, Lim W, Ferrari P, Witt CS, Christiansen FT.

Transpl Immunol. 2013 Jun;28(4):148-53. doi: 10.1016/j.trim.2013.05.001. Epub 2013 May 9.

PMID:
23665534
[PubMed - indexed for MEDLINE]
3.

Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival.

Ho EK, Vlad G, Vasilescu ER, de la Torre L, Colovai AI, Burke E, Deng M, Schwartz J, Marboe C, Mancini D, Opelz G, Suciu-Foca N.

Hum Immunol. 2011 Jan;72(1):5-10. doi: 10.1016/j.humimm.2010.10.013. Epub 2010 Nov 10.

PMID:
20971146
[PubMed - indexed for MEDLINE]
4.

Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.

Wu P, Jin J, Everly MJ, Lin C, Terasaki PI, Chen J.

Clin Biochem. 2013 Oct;46(15):1389-93. doi: 10.1016/j.clinbiochem.2013.05.053. Epub 2013 May 29.

PMID:
23726814
[PubMed - indexed for MEDLINE]
5.

Class II alloantibody and mortality in simultaneous liver-kidney transplantation.

O'Leary JG, Gebel HM, Ruiz R, Bray RA, Marr JD, Zhou XJ, Shiller SM, Susskind BM, Kirk AD, Klintmalm GB.

Am J Transplant. 2013 Apr;13(4):954-60. doi: 10.1111/ajt.12147. Epub 2013 Feb 22.

PMID:
23433356
[PubMed - indexed for MEDLINE]
Free Article
6.

Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.

Tait BD, Süsal C, Gebel HM, Nickerson PW, Zachary AA, Claas FH, Reed EF, Bray RA, Campbell P, Chapman JR, Coates PT, Colvin RB, Cozzi E, Doxiadis II, Fuggle SV, Gill J, Glotz D, Lachmann N, Mohanakumar T, Suciu-Foca N, Sumitran-Holgersson S, Tanabe K, Taylor CJ, Tyan DB, Webster A, Zeevi A, Opelz G.

Transplantation. 2013 Jan 15;95(1):19-47. doi: 10.1097/TP.0b013e31827a19cc.

PMID:
23238534
[PubMed - indexed for MEDLINE]
7.

Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.

Yamanaga S, Watarai Y, Yamamoto T, Tsujita M, Hiramitsu T, Nanmoku K, Goto N, Takeda A, Morozumi K, Katayama A, Saji H, Uchida K, Kobayashi T.

Hum Immunol. 2013 Sep;74(9):1111-8. doi: 10.1016/j.humimm.2013.06.022. Epub 2013 Jun 18.

PMID:
23792054
[PubMed - indexed for MEDLINE]
8.

Risk of antibody-mediated rejection in kidney transplant recipients with anti-HLA-C donor-specific antibodies.

Aubert O, Bories MC, Suberbielle C, Snanoudj R, Anglicheau D, Rabant M, Martinez F, Scemla A, Legendre C, Sberro-Soussan R.

Am J Transplant. 2014 Jun;14(6):1439-45. doi: 10.1111/ajt.12709. Epub 2014 May 7.

PMID:
24804568
[PubMed - in process]
9.

Preformed and de novo donor specific antibodies in visceral transplantation: long-term outcome with special reference to the liver.

Abu-Elmagd KM, Wu G, Costa G, Lunz J, Martin L, Koritsky DA, Murase N, Irish W, Zeevi A.

Am J Transplant. 2012 Nov;12(11):3047-60. doi: 10.1111/j.1600-6143.2012.04237.x. Epub 2012 Sep 4.

PMID:
22947059
[PubMed - indexed for MEDLINE]
Free Article
10.

Targeted monitoring of donor-specific HLA antibodies following renal transplantation.

Almeshari K, Pall A, Chaballout A, Elgamal H, Almana H, Alzayer F, Abaalkhail N, Altalhi M.

Clin Transpl. 2011:395-400.

PMID:
22755437
[PubMed - indexed for MEDLINE]
11.

Preformed Donor-Specific Antibodies and Risk of Antibody-Mediated Rejection in Repeat Renal Transplantation.

Tsapepas DS, Vasilescu R, Tanriover B, Coppleson Y, Rekhtman Y, Hardy MA, Dube G, Crew RJ, Ratner LE, Cohen DJ, Mohan S.

Transplantation. 2013 Dec 20. [Epub ahead of print]

PMID:
24356472
[PubMed - as supplied by publisher]
12.

Impact of donor-specific antibodies on results of liver transplantation.

O'Leary JG, Klintmalm GB.

Curr Opin Organ Transplant. 2013 Jun;18(3):279-84. doi: 10.1097/MOT.0b013e3283614a10. Review.

PMID:
23591739
[PubMed - indexed for MEDLINE]
13.

Renal allograft pathology in the sensitized patient.

Cornell LD.

Curr Opin Organ Transplant. 2013 Jun;18(3):327-36. doi: 10.1097/MOT.0b013e3283614c5a. Review.

PMID:
23619513
[PubMed - indexed for MEDLINE]
14.

The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.

Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, Leverson GE, Bellingham JM, Fernandez LA, Foley DP, Mezrich JD, D'Alessandro AM, Lucey MR.

Am J Transplant. 2011 Mar;11(3):500-10. doi: 10.1111/j.1600-6143.2010.03414.x.

PMID:
21342448
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Donor-specific anti-HLA antibody monitoring and removal in solid organ transplant recipients.

Everly MJ.

Clin Transpl. 2011:319-25. Review.

PMID:
22755425
[PubMed - indexed for MEDLINE]
16.

Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation.

Gloor JM, Winters JL, Cornell LD, Fix LA, DeGoey SR, Knauer RM, Cosio FG, Gandhi MJ, Kremers W, Stegall MD.

Am J Transplant. 2010 Mar;10(3):582-9. doi: 10.1111/j.1600-6143.2009.02985.x. Epub 2010 Jan 29.

PMID:
20121740
[PubMed - indexed for MEDLINE]
Free Article
17.

Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients.

Bartel G, Wahrmann M, Schwaiger E, Kikić Ž, Winzer C, Hörl WH, Mühlbacher F, Hoke M, Zlabinger GJ, Regele H, Böhmig GA.

Transpl Int. 2013 Feb;26(2):121-30. doi: 10.1111/tri.12000. Epub 2012 Nov 12.

PMID:
23145861
[PubMed - indexed for MEDLINE]
18.

Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.

Vlad G, Ho EK, Vasilescu ER, Colovai AI, Stokes MB, Markowitz GS, D'Agati VD, Cohen DJ, Ratner LE, Suciu-Foca N.

Hum Immunol. 2009 Aug;70(8):589-94. doi: 10.1016/j.humimm.2009.04.018. Epub 2009 Apr 15.

PMID:
19375470
[PubMed - indexed for MEDLINE]
19.

Influence of preformed donor-specific antibodies and C4d on early liver allograft function.

Perera MT, Silva MA, Murphy N, Briggs D, Mirza DF, Neil DA.

Scand J Gastroenterol. 2013 Dec;48(12):1444-51. doi: 10.3109/00365521.2013.845795. Epub 2013 Oct 16.

PMID:
24131305
[PubMed - in process]
20.

[Indications for apheresis in kidney transplant recipients: apheresis in the hyperimmune patient].

Busnach G, Di Leo L.

G Ital Nefrol. 2012 Jan-Feb;29 Suppl 54:S22-6. Italian.

PMID:
22388825
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk